Alternative Splicing and Protein Structure Evolution

Total Page:16

File Type:pdf, Size:1020Kb

Alternative Splicing and Protein Structure Evolution Alternative Splicing and Protein Structure Evolution Fabian Birzele Munchen¨ 2008 Alternative Splicing and Protein Structure Evolution Fabian Birzele Dissertation an der Fakultat¨ fur¨ Mathematik, Informatik und Statistik der Ludwig–Maximilians–Universitat¨ Munchen¨ vorgelegt von Fabian Birzele aus Wurzburg¨ Munchen,¨ den 09.12.2008 Erstgutachter: Prof. Dr. Ralf Zimmer Zweitgutachter: Prof. Dr. Dimtrij Frishman Tag der mundlichen¨ Prufung:¨ 27.01.2009 Contents Abstract xiii Zusammenfassung xv 1 Introduction 1 I Protein Structure Comparison 7 2 Introduction to Protein Structure Analysis 9 2.1 Goals and open questions in protein structure analysis . 9 2.2 Existing approaches to protein structure comparison . 10 2.2.1 SCOP and CATH - the standard of truth . 10 2.2.2 Automated protein structure alignment and comparison . 11 3 A Systematic Comparison of SCOP and CATH 13 3.1 Methods . 14 3.1.1 Mapping of domain assignments . 14 3.1.2 Mapping inner nodes of the hierarchies . 15 3.2 Results . 15 3.2.1 Datasets . 15 3.2.2 Detailed Comparison of SCOP and CATH . 16 3.3 Applications of the SCOP-CATH mapping . 20 3.3.1 Benchmarking Structure-Comparison methods . 20 3.3.2 Inter-Fold Similarities revealed by Consistency Checks . 24 3.4 Conclusion . 25 4 Protein Structure Alignment considering Phenotypic Plasticity 27 4.1 Outline of the method . 29 4.2 Conclusion . 30 5 Vorolign - fast protein structure alignment using Voronoi contacts 33 5.1 Methods . 34 5.1.1 Voronoi tessellation of protein structures . 34 vi CONTENTS 5.1.2 Properties of Voronoi cells . 35 5.1.3 Similarity of Voronoi cells . 36 5.1.4 Pairwise alignment of protein structures . 37 5.1.5 Multiple alignment of protein structures . 38 5.1.6 Fast scan for family members: VorolignScan . 39 5.1.7 Automatic detection of domains in multi-domain structures . 40 5.1.8 Parameter Optimization . 40 5.2 Results . 41 5.2.1 Family recognition on a testset of 979 query proteins . 41 5.2.2 Detailed Evaluation on the SCOP-CATH set . 43 5.2.3 Alignment quality . 46 5.2.4 Specific examples for multiple alignment of protein structures . 47 5.2.5 Large scale evaluation of multiple alignment quality . 49 5.3 The AutoPSI database . 52 5.3.1 The current database content . 52 5.3.2 Database access . 53 5.4 Voronoi contact patterns around functionally important sites . 55 5.4.1 Outline of the method . 56 5.4.2 Results: Case study of the Trypsin-like serine protease family . 58 5.4.3 Discussion . 60 5.5 Conclusions . 61 II Alternative Splicing in the Context of Protein Structure 63 6 Introduction to the Analysis of Alternative Splicing 65 6.1 Fundamentals of alternative splicing . 66 6.1.1 The splicing process in the cell . 66 6.1.2 Different types of alternative splicing events . 66 6.1.3 Regulation of alternative splicing . 67 6.2 Biological functions of alternative splicing events . 68 6.3 Alternative splicing and disease . 69 7 Alternative Splicing and Protein Structure Evolution 71 7.1 Hypotheses and major concepts . 72 7.2 Methods . 72 7.2.1 Alternative splicing and literature data . 73 7.2.2 Protein structure assignment . 73 7.2.3 Assignment of protein structures to families . 74 7.2.4 Multiple structure alignments and evolutionary ”isoforms” . 74 7.2.5 Alternative splicing and alternative structural models . 74 7.3 Results . 75 7.3.1 Structural complexity of functional isoforms . 75 CONTENTS vii 7.3.2 Interpretation of splicing events using evolutionary isoforms . 79 7.3.3 Supporting hypotheses on fold evolution via alternative splicing data . 80 7.3.4 Alternative splicing: a mechanism to explore the protein fold space? . 81 7.4 Discussion . 84 8 Alternative Splicing and Protein Repeats 87 8.1 Methods . 88 8.1.1 Genomic data and annotated splice variants . 88 8.1.2 Splicing events annotated in Swissprot . 88 8.1.3 Repeat assignment and data collection . 89 8.1.4 Assessing the statistical significance of the results . 89 8.2 Results . 89 8.2.1 Frequency of repeats in Swissprot and Ensembl . 89 8.2.2 Alternative splicing of proteins containing repeats . 90 8.2.3 Alternative splicing of C2H2-Zinc-finger motifs . 94 8.2.4 Sculpting protein binding domains - Ankyrin repeats . 95 8.2.5 Alternative splicing of β-propellers . 97 8.2.6 Importance of splicing for complex tissue organizations . 97 8.3 Discussion . 98 III Genome-wide Detection and Analysis of Alternative Splicing 101 9 Detection and prediction of Alternative Splicing Events 103 10 The ProSAS - Database 107 10.1 The ProSAS pipeline . 107 10.1.1 Genome and alternative splicing data . 108 10.1.2 Protein structure prediction . 108 10.1.3 Characterization of splicing events . 109 10.1.4 Affymetrix data mapping . 110 10.1.5 Further data sources . 110 10.2 The ProSAS database content . 110 10.3 The ProSAS database web interface . 112 10.4 Conclusion . 115 11 PASS - Identifying splicing events in Affymetrix Exon Arrays 117 11.1 Outline of the method . 117 11.2 Results and Discussion . 119 12 Alternative splicing and proteome complexity in mass spectrometry data 123 12.1 Methods . 124 12.1.1 Identification of isoforms in precompiled MS peptide datasets . 124 12.1.2 Expected versus observed unique isoform peptides . 124 viii Contents 12.1.3 Sequence-based analysis of alternative splicing . 125 12.1.4 Protein structure prediction pipeline . 125 12.2 Results . 125 12.2.1 Presence of isoforms in mass spectrometry data . 126 12.2.2 Changing signal peptides, localization and domain composition via al- ternative splicing . 128 12.2.3 Structural analysis of isoforms identified in mass spectrometry data . 130 12.3 Discussion . 134 12.4 Outlook: Identification of novel splice variants in mass spectrometry data . 135 IV Conclusions and Outlook 139 13 Conclusion and Outlook 141 Bibliography 147 Acknowledgements 163 Curriculum Vitae 165 List of Figures 3.1 Examples of interfold similarities detected by the systematic comparison of SCOP and CATH . 21 3.2 Evaluation of the performance of TM-align on SCOP and the novel benchmark set of consistently classified pairs of structures . 22 4.1 Phenotypic plasticity observed in the pheromone binding domain family (a.39.2.1) 28 4.2 Schematic overview on the single steps of the PPM method . 29 5.1 Anomaly in a structural alignment due to structural divergence . 34 5.2 Construction of a two-dimensional Voronoi tessellation . 35 5.3 Basic principle of the Vorolign scoring function to score the similarity of two Voronoi cells . 38 5.4 Detailed evaluation of the performance of PPM and Vorolign on the SCOP- CATH consensus set . 45 5.5 Structural quality of Vorolign alignments across different sequence identities in more than 8000 pairs of structures from the same SCOP family . 46 5.6 Flexible structural alignment of members of the Calmodulin family computed by Vorolign . 47 5.7 Pairwise Vorolign alignment quality induced from multiple structure alignments of more than 800 SCOP families . 49 5.8 Conservation rate of biologically relevant residues (CSA patterns and cystein bridges) in multiple structure alignments . 51 5.9 Conservation rate of biologically relevant residues (PROSITE patterns and Swis- sprot annotated functional residues) in multiple structure alignments . 51 5.10 Detail view in the AutoPSI database web interface . 54 5.11 Schematic example of the consistency check in the Vorolign Pattern identifica- tion method . 57 5.12 PROSITE pattern matches of the catalytic triad on the Trypsin structure (PDB: 1a0j) . 58 5.13 Initial Voronoi pattern in the Trypsin structure (PDB: 1a0j) . 59 5.14 Final consensus Voronoipattern for eukaryotic Tyrpsin-like serine proteases fam- ily (SCOP: b.47.1.2) . 60 x List of Figures 6.1 Important consensus splicing signals in intronic sequences . 66 6.2 Different types of alternative splicing events . 67 7.1 Schematic.
Recommended publications
  • DFFA Monoclonal Antibody (M05), Degradation of the Chromosomal DNA Into Nucleosomal Clone 3A11 Units
    DFFA monoclonal antibody (M05), degradation of the chromosomal DNA into nucleosomal clone 3A11 units. DNA fragmentation factor (DFF) is a heterodimeric protein of 40-kD (DFFB) and 45-kD (DFFA) subunits. Catalog Number: H00001676-M05 DFFA is the substrate for caspase-3 and triggers DNA fragmentation during apoptosis. DFF becomes activated Regulatory Status: For research use only (RUO) when DFFA is cleaved by caspase-3. The cleaved fragments of DFFA dissociate from DFFB, the active Product Description: Mouse monoclonal antibody component of DFF. DFFB has been found to trigger both raised against a partial recombinant DFFA. DNA fragmentation and chromatin condensation during apoptosis. Two alternatively spliced transcript variants Clone Name: 3A11 encoding distinct isoforms have been found for this gene. [provided by RefSeq] Immunogen: DFFA (NP_004392.1, 231 a.a. ~ 331 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. Sequence: TSSDVALASHILTALREKQAPELSLSSQDLELVTKEDPK ALAVALNWDIKKTETVQEACERELALRLQQTQSLHSLR SISASKASPPGDLQNPKRARQDPT Host: Mouse Reactivity: Human Applications: ELISA, PLA-Ce, S-ELISA, WB-Re, WB-Tr (See our web site product page for detailed applications information) Protocols: See our web site at http://www.abnova.com/support/protocols.asp or product page for detailed protocols Isotype: IgG2a Kappa Storage Buffer: In 1x PBS, pH 7.4 Storage Instruction: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. Entrez GeneID: 1676 Gene Symbol: DFFA Gene Alias: DFF-45, DFF1, ICAD Gene Summary: Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and Page 1/1 Powered by TCPDF (www.tcpdf.org).
    [Show full text]
  • DFFB (NM 004402) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC208266 DFFB (NM_004402) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: DFFB (NM_004402) Human Tagged ORF Clone Tag: Myc-DDK Symbol: DFFB Synonyms: CAD; CPAN; DFF-40; DFF2; DFF40 Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin ORF Nucleotide >RC208266 ORF sequence Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGCTCCAGAAGCCCAAGAGCGTGAAGCTGCGGGCCCTGCGCAGCCCGAGGAAGTTCGGCGTGGCTGGCC GGAGCTGCCAGGAGGTGCTGCGCAAGGGCTGTCTCCGCTTCCAGCTCCCTGAGCGCGGTTCCCGGCTGTG CCTGTACGAGGATGGCACGGAGCTGACGGAAGATTACTTCCCCAGTGTTCCCGACAACGCCGAGCTGGTG CTGCTCACCTTGGGCCAGGCCTGGCAGGGCTATGTGAGCGACATCAGGCGCTTCCTCAGTGCATTTCACG AGCCACAGGTGGGGCTCATCCAGGCCGCCCAGCAGCTGCTGTGTGATGAGCAGGCCCCACAGAGGCAGAG GCTGCTGGCTGACCTCCTGCACAACGTCAGCCAGAACATCGCGGCCGAGACCCGGGCTGAGGACCCGCCG TGGTTTGAAGGCTTGGAGTCCCGATTTCAGAGCAAGTCTGGCTATCTGAGATACAGCTGTGAGAGCCGGA TCCGGAGTTACCTGAGGGAGGTGAGCTCCTACCCCTCCACAGTGGGTGCGGAGGCTCAGGAGGAATTCCT GCGGGTCCTCGGCTCCATGTGCCAGAGGCTCCGGTCCATGCAGTACAATGGCAGCTACTTCGACAGAGGA GCCAAGGGCGGCAGCCGCCTCTGCACACCGGAAGGCTGGTTCTCCTGCCAGGGTCCCTTTGACATGGACA GCTGCTTATCAAGACACTCCATCAACCCCTACAGTAACAGGGAGAGCAGGATCCTCTTCAGCACCTGGAA CCTGGATCACATAATAGAAAAGAAACGCACCATCATTCCTACACTGGTGGAAGCAATTAAGGAACAAGAT GGAAGAGAAGTGGACTGGGAGTATTTTTATGGCCTGCTTTTTACCTCAGAGAACCTAAAACTAGTGCACA
    [Show full text]
  • ICAD Antibody Cat
    ICAD Antibody Cat. No.: 2003 ICAD Antibody Immunofluorescence of ICAD in mouse kidney tissue with ICAD antibody at 5 μg/ml. Immunohistochemistry of ICAD in mouse kidney tissue with ICAD antibody at 5 μg/ml. Green: ICAD antibody (2003) Red: Phylloidin staining Blue: DAPI staining Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Mouse ICAD antibody was raised against a 20 amino acid peptide near the carboxy terminus of mouse ICAD. IMMUNOGEN: The immunogen is located within the last 50 amino acids of ICAD. TESTED APPLICATIONS: ELISA, IF, IHC-P, WB September 28, 2021 1 https://www.prosci-inc.com/icad-antibody-2003.html ICAD antibody can be used for detection of of ICAD by Western blot at 1:1000 dilution. A 45 kDa band can be detected. Antibody can also be used for immunohistochemistry starting at 5 μg/mL. For immunofluorescence start at 5 μg/mL. APPLICATIONS: Antibody validated: Western Blot in mouse samples; Immunohistochemistry in mouse samples and Immunofluorescence in mouse samples. All other applications and species not yet tested. POSITIVE CONTROL: 1) Cat. No. 1402 - Mouse Lung Tissue Lysate PREDICTED MOLECULAR 45 kDa WEIGHT: Properties PURIFICATION: ICAD Antibody is affinity chromatography purified via peptide column. CLONALITY: Polyclonal ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: ICAD Antibody is supplied in PBS containing 0.02% sodium azide. CONCENTRATION: 1 mg/ml ICAD antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. STORAGE CONDITIONS: As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
    [Show full text]
  • Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination
    Published OnlineFirst February 4, 2013; DOI: 10.1158/0008-5472.CAN-12-4400 Cancer Molecular and Cellular Pathobiology Research Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination Bridgid E. Hast1, Dennis Goldfarb2, Kathleen M. Mulvaney1, Michael A. Hast4, Priscila F. Siesser1, Feng Yan1, D. Neil Hayes3, and Michael B. Major1,2 Abstract Somatic mutations in the KEAP1 ubiquitin ligase or its substrate NRF2 (NFE2L2) commonly occur in human cancer, resulting in constitutive NRF2-mediated transcription of cytoprotective genes. However, many tumors display high NRF2 activity in the absence of mutation, supporting the hypothesis that alternative mechanisms of pathway activation exist. Previously, we and others discovered that via a competitive binding mechanism, the proteins WTX (AMER1), PALB2, and SQSTM1 bind KEAP1 to activate NRF2. Proteomic analysis of the KEAP1 protein interaction network revealed a significant enrichment of associated proteins containing an ETGE amino acid motif, which matches the KEAP1 interaction motif found in NRF2. Like WTX, PALB2, and SQSTM1, we found that the dipeptidyl peptidase 3 (DPP3) protein binds KEAP1 via an "ETGE" motif to displace NRF2, thus inhibiting NRF2 ubiquitination and driving NRF2-dependent transcription. Comparing the spectrum of KEAP1-interacting proteins with the genomic profile of 178 squamous cell lung carcinomas characterized by The Cancer Genome Atlas revealed amplification and mRNA overexpression of the DPP3 gene in tumors with high NRF2 activity but lacking NRF2 stabilizing mutations. We further show that tumor-derived mutations in KEAP1 are hypomorphic with respect to NRF2 inhibition and that DPP3 overexpression in the presence of these mutants further promotes NRF2 activation.
    [Show full text]
  • Produktinformation
    Produktinformation Diagnostik & molekulare Diagnostik Laborgeräte & Service Zellkultur & Verbrauchsmaterial Forschungsprodukte & Biochemikalien Weitere Information auf den folgenden Seiten! See the following pages for more information! Lieferung & Zahlungsart Lieferung: frei Haus Bestellung auf Rechnung SZABO-SCANDIC Lieferung: € 10,- HandelsgmbH & Co KG Erstbestellung Vorauskassa Quellenstraße 110, A-1100 Wien T. +43(0)1 489 3961-0 Zuschläge F. +43(0)1 489 3961-7 [email protected] • Mindermengenzuschlag www.szabo-scandic.com • Trockeneiszuschlag • Gefahrgutzuschlag linkedin.com/company/szaboscandic • Expressversand facebook.com/szaboscandic DFFA Recombinant Protein (OPCD02721) Data Sheet Product Number OPCD02721 Product Page http://www.avivasysbio.com/dffa-recombinant-protein-opcd02721.html Product Name DFFA Recombinant Protein (OPCD02721) Size 10 ug Gene Symbol DFFA Alias Symbols A330085O09Rik, DFF35, Dff45, DFF-45, DNA fragmentation factor 45 kDa subunit, DNA fragmentation factor subunit alpha, Icad, ICAD, ICAD-L, IC AD-S, Inhibitor of CAD Molecular Weight 31 kDa Product Format Lyophilized Tag N-terminal His Tag Conjugation Unconjugated NCBI Gene Id 13347 Host E.coli Purity > 95% Source Prokaryotic Expressed Recombinant Official Gene Full Name DNA fragmentation factor, alpha subunit Description of Target Inhibitor of the caspase-activated DNase (DFF40). Reconstitution and Storage Reconstitute in PBS or others. Store at 2-8C for one month. Aliquot and store at -80C for 12 months. Avoid repeated freeze/thaw cycles. Additional Information Endotoxin Level: < 1.0 EU per 1 ug (determined by the LAL method) Additional Information Residues: Lys19 - Ser262 Lead Time Domestic: within 1-2 weeks delivery International: 1-3 weeks Formulation Lyophilized in PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
    [Show full text]
  • Anti-ICAD Antibody (ARG54401)
    Product datasheet [email protected] ARG54401 Package: 50 μg anti-ICAD antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes ICAD Tested Reactivity Hu Tested Application ICC/IF, WB Specificity This antibody recognizes non-cleaved (45kDa) and cleaved DFF45. Host Rabbit Clonality Polyclonal Isotype IgG Target Name ICAD Antigen Species Human Immunogen Peptide corresponding to aa 313-331 at the C-terminus of human DFF45 (accession no. NP_004392). Conjugation Un-conjugated Alternate Names DFF-45; DNA fragmentation factor 45 kDa subunit; Inhibitor of CAD; ICAD; DFF1; DNA fragmentation factor subunit alpha Application Instructions Application table Application Dilution ICC/IF Assay-dependent WB Assay-dependent Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control HeLa, Jurkat, A431 and K562 Calculated Mw 37 kDa Properties Form Liquid Purification Immunoaffinity chroma-tography Buffer PBS (pH 7.4) and 0.02% Sodium azide Preservative 0.02% Sodium azide Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. www.arigobio.com 1/2 Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Database links GeneID: 1676 Human Swiss-port # O00273 Human Gene Symbol DFFA Gene Full Name DNA fragmentation factor, 45kDa, alpha polypeptide Background A human DNA fragmentation factor (DFF) which is cleaved by caspase-3 during apoptosis was identified recently.
    [Show full text]
  • DFFA Antibody Cat
    DFFA Antibody Cat. No.: 27-308 DFFA Antibody Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human Antibody produced in rabbits immunized with a synthetic peptide corresponding a region IMMUNOGEN: of human DFFA. TESTED APPLICATIONS: ELISA, WB DFFA antibody can be used for detection of DFFA by ELISA at 1:312500. DFFA antibody can APPLICATIONS: be used for detection of DFFA by western blot at 5.0 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000. POSITIVE CONTROL: 1) Cat. No. 1205 - Jurkat Cell Lysate PREDICTED MOLECULAR 37 kDa, 29 kDa WEIGHT: Properties PURIFICATION: Antibody is purified by protein A chromatography method. CLONALITY: Polyclonal CONJUGATE: Unconjugated PHYSICAL STATE: Liquid September 29, 2021 1 https://www.prosci-inc.com/dffa-antibody-27-308.html Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% BUFFER: sucrose. CONCENTRATION: batch dependent For short periods of storage (days) store at 4˚C. For longer periods of storage, store DFFA STORAGE CONDITIONS: antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles. Additional Info OFFICIAL SYMBOL: DFFA ALTERNATE NAMES: DFFA, DFF-45, DFF1, Ion ChannelAD, ICAD ACCESSION NO.: NP_004392 PROTEIN GI NO.: 4758148 GENE ID: 1676 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and degradation of the chromosomal DNA into nucleosomal units. DNA fragmentation factor (DFF) is a heterodimeric protein of 40-kD (DFFB) and 45-kD (DFFA) subunits.
    [Show full text]
  • Primepcr™Assay Validation Report
    PrimePCR™Assay Validation Report Gene Information Gene Name DNA fragmentation factor, 45kDa, alpha polypeptide Gene Symbol DFFA Organism Human Gene Summary Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and degradation of the chromosomal DNA into nucleosomal units. DNA fragmentation factor (DFF) is a heterodimeric protein of 40-kD (DFFB) and 45-kD (DFFA) subunits. DFFA is the substrate for caspase-3 and triggers DNA fragmentation during apoptosis. DFF becomes activated when DFFA is cleaved by caspase-3. The cleaved fragments of DFFA dissociate from DFFB the active component of DFF. DFFB has been found to trigger both DNA fragmentation and chromatin condensation during apoptosis. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. Gene Aliases DFF-45, DFF1, ICAD RefSeq Accession No. NC_000001.10, NG_008340.1, NT_021937.19 UniGene ID Hs.484782 Ensembl Gene ID ENSG00000160049 Entrez Gene ID 1676 Assay Information Unique Assay ID qHsaCID0012769 Assay Type SYBR® Green Detected Coding Transcript(s) ENST00000377038, ENST00000377036 Amplicon Context Sequence CTGGCCACATTCTTCCACTTCAACCCTGCCCCGCTGTCTGTTTCATCTACATCAA AGGACTCTTGGGAAATCCAAGCTGTACCTCCATCTGAATTGTTGTATGCCCATTT CTCATTACTAGCCAATGCCACAAACTTAGTATTGGAAGGTAGACACA Amplicon Length (bp) 127 Chromosome Location 1:10527302-10529302 Assay Design Intron-spanning Purification Desalted Validation Results
    [Show full text]
  • Proteome-Scale Prediction of Structure and Func- Tion
    Downloaded from genome.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press The proteome folding project: proteome-scale prediction of structure and func- tion Kevin Drew 1, Patrick Winters 1, Glenn L. Butterfoss 1, Viktors Berstis 2, Keith Uplinger 2, Jonathan Armstrong 2, Michael Riffle 3, Erik Schweighofer 4, Bill Bovermann 2, David R. Good- lett 5, Trisha N. Davis 3, Dennis Shasha 6, Lars Malmström 7, Richard Bonneau 1,4,6 * 1 Center for Genomics and Systems Biology, Department of Biology, New York University, New York, NY 10003, USA 2 IBM, Austin, TX, 78758, USA 3 Department of Biochemistry, Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA 4 Institute for Systems Biology, Seattle, WA 98103, USA 5 Medicinal Chemistry Department, University of Washington, Seattle, WA 98195, USA 6 Department of Computer Science, Courant Institute of Mathematical Sciences, New York University, New York, New York, 10003, USA 7 Institute of Molecular Systems Biology, ETH Zurich, Zurich CH 8093, Switzerland * To whom correspondence should be addressed. Richard Bonneau, PhD. New York University Center for Genomics and Systems Biology 100 Washington Sq. E. 1009 Main Building New York, NY 10003 Voice: 646 460 3026 Email: [email protected] Running title: proteome folding Keywords: proteome, de novo folding, function prediction, Rosetta, grid computing 1 Downloaded from genome.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press 2 Downloaded from genome.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract: The incompleteness of proteome structure and function annotation is a critical problem for biol- ogists and, in particular, severely limits interpretation of high-throughput and next-generation experiments.
    [Show full text]
  • DFFA Conjugated Antibody
    Product Datasheet DFFA Conjugated Antibody Catalog No: #C27370 Package Size: #C27370-AF350 100ul #C27370-AF405 100ul #C27370-AF488 100ul Orders: [email protected] Support: [email protected] #C27370-AF555 100ul #C27370-AF594 100ul #C27370-AF647 100ul #C27370-AF680 100ul #C27370-AF750 100ul #C27370-Biotin 100ul Description Product Name DFFA Conjugated Antibody Host Species Rabbit Clonality Polyclonal Isotype IgG Purification Affinity purification Applications most applications Species Reactivity Hu,Ms,Rt Immunogen Description Recombinant fusion protein of human DFFA (NP_004392.1). Conjugates Biotin AF350 AF405 AF488 AF555 AF594 AF647 AF680 AF750 Other Names DFFA; DFF-45; DFF1; ICAD; DNA fragmentation factor subunit alpha Accession No. Swiss-Prot#:O00273NCBI Gene ID:1676 Calculated MW 35kDa, 45kDa Formulation 0.01M Sodium Phosphate, 0.25M NaCl, pH 7.6, 5mg/ml Bovine Serum Albumin, 0.02% Sodium Azide Storage Store at 4°C in dark for 6 months Application Details Suggested Dilution: AF350 conjugated: most applications: 1: 50 - 1: 250 AF405 conjugated: most applications: 1: 50 - 1: 250 AF488 conjugated: most applications: 1: 50 - 1: 250 AF555 conjugated: most applications: 1: 50 - 1: 250 AF594 conjugated: most applications: 1: 50 - 1: 250 AF647 conjugated: most applications: 1: 50 - 1: 250 AF680 conjugated: most applications: 1: 50 - 1: 250 AF750 conjugated: most applications: 1: 50 - 1: 250 Biotin conjugated: working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000 Background Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and degradation of the chromosomal DNA into nucleosomal units.
    [Show full text]
  • Anti-DFFA Polyclonal Antibody Cat: K001939P Summary
    Anti-DFFA Polyclonal Antibody Cat: K001939P Summary: 【Product name】: Anti-DFFA antibody 【Source】: Rabbit 【Isotype】: IgG 【Species reactivity】: Human Mouse Rat 【Swiss Prot】: O00273 【Gene ID】: 1676 【Calculated】: MW: 29/36kDa 【Observed】: MW: 36kDa 【Purification】: Affinity purification 【Tested applications】: WB IHC IF 【Recommended dilution】: WB 1:500-2000. IHC 1:50-200. IF 1:50-100. 【WB Positive sample】: HepG2 【IHC Positive sample】: Human breast cancer 【Subcellular location】: Cytoplasm. 【Immunogen】: Recombinant protein of human DFFA. 【Storage】: Shipped at 4°C. Upon delivery aliquot and store at -20°C Background: Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and degradation of the chromosomal DNA into nucleosomal units. DNA fragmentation factor (DFF) is a heterodimeric protein of 40-kD (DFFB) and 45-kD (DFFA) subunits. DFFA is the substrate for caspase-3 and triggers DNA fragmentation during apoptosis. DFF becomes activated when DFFA is cleaved by caspase-3. The cleaved fragments of DFFA dissociate from DFFB, the active component of DFF. DFFB has been found to trigger both DNA fragmentation and chromatin condensation during apoptosis. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. Sales:[email protected] For research purposes only. Tech:[email protected] Please visit www.solarbio.com for a more product information Verified picture Western blot analysis with DFFA antibody Immunohistochemistry of paraffin-embedded diluted at 1:1000 Human breast cancer with DFFA antibody diluted at 1:100 Sales:[email protected] For research purposes only.
    [Show full text]
  • The History of the CATH Structural Classification of Protein Domains
    Accepted Manuscript The History of the CATH Structural Classification of Protein Domains Ian Sillitoe, Natalie Dawson, Janet Thornton, Christine Orengo PII: S0300-9084(15)00251-5 DOI: 10.1016/j.biochi.2015.08.004 Reference: BIOCHI 4793 To appear in: Biochimie Received Date: 1 July 2015 Accepted Date: 1 August 2015 Please cite this article as: I. Sillitoe, N. Dawson, J. Thornton, C. Orengo, The History of the CATH Structural Classification of Protein Domains, Biochimie (2015), doi: 10.1016/j.biochi.2015.08.004. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. ACCEPTED MANUSCRIPT The History of the CATH Structural Classification of Protein Domains Ian Sillitoe*, Natalie Dawson, Janet Thornton and Christine Orengo University College London Darwin Building, Gower Street, University College London, WC1E 6BT, UK * Corresponding author: Email: [email protected] Phone: +442076792171 MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT Abstract This article presents a historical review of the protein structure classification database CATH. Together with the SCOP database, CATH remains comprehensive and reasonably up-to-date with the now more than 100,000 protein structures in the PDB. We review the expansion of the CATH and SCOP resources to capture predicted domain structures in the genome sequence data and to provide information on the likely functions of proteins mediated by their constituent domains.
    [Show full text]